Iovance Biotherapeutics Inc
IOVAHealthcare|Biotechnology|USA
$4.23
-0.13 (-2.98%)
Tangible Book
$1.03
Upcoming Data Readouts (14)
Sep 2026
Est. completion
P1Gastric Cancer
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
NCT05483491n=30
Oct 2026
Est. completion
P1P2HPV-Associated Cervical Carcinoma
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
NCT05639972n=15
Nov 2026
Est. completion
P1Metastatic Melanoma
A Study of LN-144 in People With Metastatic Melanoma to the Brain
NCT05640193n=10
Jan 2027
Est. completion
P2Cervical Cancer
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
NCT05686226n=20
Apr 2027
Est. completion
P2Bone Sarcoma
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
NCT03449108n=30
May 2027
Est. completion
P1Uveal Melanoma
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
NCT05607095n=40
Sep 2027
Est. completion
P1P2Unresectable Melanoma
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
NCT05361174n=53
Mar 2028
Est. completion
P3Metastatic Melanoma
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
NCT05727904n=670
May 2028
Est. completion
P2Endometrial Cancer
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
NCT06481592n=60
Sep 2028
Est. completion
Dec 2030
Est. completion
P2Metastatic Non Small Cell Lung Cancer
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
NCT04614103n=170
Jun 2032
Est. completion
P1P2Unresectable Melanoma
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
NCT06940739n=42
Dec 2032
Est. completion
P2Melanoma (Skin Cancer)
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
NCT07288203n=100
Dec 2032
Est. completion
P1Malignant Pleural Effusion
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
NCT07192900n=10
Awaiting Results (3)
Trials past primary completion date but still active — data readout may be imminent.
Jul 2026
P1
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
NCT06566092Jul 2023
P1
Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients
NCT05176470Aug 2017
P1
Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
NCT01937468